论文信息 - Evaluation of safety and tolerability of durvalumab (D) with or without tremelimumab (T) in patients (pts) with biliary tract cancer (BTC). - 字舞流文

Evaluation of safety and tolerability of durvalumab (D) with or without tremelimumab (T) in patients (pts) with biliary tract cancer (BTC).

Y. Doki | Keunchil Park | M. Ikeda | Jen‐Shi Chen | G. Vlahović | N. Mizuno | D. Oh | T. Ioka | M. Ueno | Y. Fujiwara | Masahiro Nii | A. Asagi | M. Hayama | K. Komuro | M. Sugimoto